Clinical Trials Logo

Filter by:
NCT ID: NCT04910451 Recruiting - Myopia Clinical Trials

Investigating the Safety and Effect of Overnight Orthokeratology and Its Influencing Factors

Start date: July 1, 2020
Phase:
Study type: Observational

To investigate the Safety and Effect of Overnight Orthokeratology and Its Influencing Factors in China

NCT ID: NCT04910256 Recruiting - Ischemic Stroke Clinical Trials

Investigation of Huatuo Zaizao Pill in Treating Phlegm and Blood-stasis Blocking Collaterals Pattern of Ischemic Stroke Patients: Study Protocol for a Randomized Controlled Trial

Start date: June 1, 2021
Phase: Phase 3
Study type: Interventional

This study is aiming to evaluate the efficacy and safety of Huatuo Zaizao pill in ischemic stroke patients who diagnosed as the phlegm and blood-stasis blocking collaterals syndrome in TCM. A total of 80 subjects will be randomly assigned to Huatuo Zaizao pill group or the control group.

NCT ID: NCT04910126 Recruiting - Soft Tissue Sarcoma Clinical Trials

Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma

Start date: November 12, 2020
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy and safety of the combination of adriamycin and Camrelizumab in the first-line treatment of advanced soft tissue sarcoma

NCT ID: NCT04909866 Recruiting - Clinical trials for Hepatocellular Carcinoma

The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label Study

Start date: January 1, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

This study is a single-center, single-arm, open-label prospective clinical trial. By recording the disease-free progression (PFS), overall survival (OS) and tumor treatment response of the included patients, it is planned to evaluate TACE, lenvatinib and carrelizumab in the treatment of BCLC B/C hepatocytes Survival benefits of cancer patients; at the same time, the immune indicators before and after treatment are tested, the dosage is optimized, and the mechanism of combination therapy in liver cancer is explored to lay the foundation for screening more suitable treatment populations; laboratory testing indicators and adverse events To observe and evaluate the safety of combined therapy; adopt immunohistochemistry, pathology, cell biology, proteomics and imagingomics methods to comprehensively evaluate the changes after combined therapy.

NCT ID: NCT04909788 Recruiting - Clinical trials for Heart Rate Variability

Factors and Characteristics of Heart Rate Variability in Runners

Start date: July 13, 2021
Phase:
Study type: Observational

The purpose of this study is to describe the variation characteristics and factors of the heart rate variability during long-distance running.

NCT ID: NCT04909697 Recruiting - Clinical trials for Acute Respiratory Distress Syndrome

Treatment of ARDS With Sivelestat Sodium

TOAWSS
Start date: April 18, 2022
Phase: Phase 4
Study type: Interventional

Neutrophil elastase (NE) released by neutrophils play an important role in inflammatory cascade and lung tissue injury of ARDS.Inhibition of NE is expected to prevent the pathophysiological process of ARDS and alleviate lung injury. Siverestat sodium is a specific inhibitor of NE, which has been proved by basic and observational clinical studies to be effective in alleviating lung injury of ARDS, but there is a lack of prospective multi-center randomized controlled clinical trials.Therefore, this study was intended to evaluate the efficacy of sivelestat sodium in the treatment of ARDS patients with SIRS in a multicenter randomized controlled clinical trial

NCT ID: NCT04909554 Recruiting - Breast Cancer Clinical Trials

MRI-based Approaches for Multi-parametric Model to Early Predict Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer

NeoMDSS
Start date: January 1, 2019
Phase:
Study type: Observational

The purpose of this clinical research is to evaluate the accuracy of a multi-parametric model based on magnetic resonance imaging (MRI) in predicting pathological complete response (pCR) after the first cycle of neoadjuvant chemotherapy (NAC) given to patients with locally advanced breast cancer, thus allowing early chemotherapy regimen modification to increase number of patients achieving pCR or save patients from toxic effects of ineffective chemotherapy.

NCT ID: NCT04909528 Recruiting - Clinical trials for Premature Ventricular Contraction

LLTS to Treat Premature Ventricular Contractions

TREAT-PVC
Start date: March 15, 2021
Phase: N/A
Study type: Interventional

This randomized control trial is designed to explore the effect of low-level tragus stimulation in patients with frequent premature ventricular contractions.

NCT ID: NCT04909489 Recruiting - Dyslipidemias Clinical Trials

PDR and SKYD of Dyslipidemia's Characteristics From the Oxidative Stress Enhancement Caused by Inhibition of Serine Metabolic Pathway

PDR SKYD
Start date: April 21, 2021
Phase:
Study type: Observational [Patient Registry]

Clinical epidemiological investigation and modern statistics will be used. Syndrome was quantified by TCM syndrome score scale. Metabonomics, proteomics, transcriptomics, enzyme-linked immunosorbent assay, xanthine oxidation method and thiobarbital method will be used to detect the relevant indicators in serum, urine and tongue coating, and "disease syndrome cell model" will be constructed to detect the relevant indicators. Objective to clarify the epigenetic basis, molecular biological regulation mechanism and core function characteristics of phgdh expression decline caused by PDR and SKYD of dyslipidemia, analyze the correlation between phgdh, serine metabolic pathway product concentration and oxidative stress level, and reveal the scientific connotation of the disease syndrome.

NCT ID: NCT04909320 Recruiting - Smoking Cessation Clinical Trials

Mobile-based Positive Psychological Support for Smoking Cessation Via "Quit to Win" Contest 2021 (QTW 2021)

Start date: June 12, 2021
Phase: N/A
Study type: Interventional

This study aims to explore the effectiveness of a combined intervention using brief cessation advice and personalized chat-based positive psychological support compared with the control group on current smokers who join the Quit to Win Contest.